SCHEMBL21291946

SCHEMBL21291946

CCC(Oc1ccccc1)OP(=O)(O)O

nearest known ligand 0.46

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
SRC P12931 1/20 0.46
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
SMPD1 P17405 3/20 0.40
ANPEP P15144 2/20 0.40
LAP3 P28838 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
MTNR1A P48039 1/20 0.38
MTNR1B P49286 1/20 0.38
TSHR P16473 1/20 0.38
ALDH1A1 P00352 1/20 0.38
MAPT P10636 1/20 0.37
POLB P06746 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21291919 0.90 CYP2C9 (0.42) SRCCYP2C9CYP2C19ANPEPLAP3
SCHEMBL28322580 0.85 ACP3 (0.42) SMPD1ANPEPMTNR1AMTNR1BALDH1A1
SCHEMBL28322574 0.83 PPARA (0.40) CYP2C9CYP2C19SMPD1TSHRPOLB
SCHEMBL22774119 0.82 SMPD1 (0.64) SMPD1ALDH1A1
SCHEMBL2186074 0.79 CA4 (0.42) MTNR1AMTNR1BTSHRALDH1A1MAPT
SCHEMBL21291924 0.79 TDP1 (0.38) SMPD1L3MBTL1TSHRALDH1A1
Ammonia Solution, Strong SCHEMBL9245393 0.77 LTA4H (0.40) MTNR1AMTNR1BTSHRALDH1A1MAPT
SCHEMBL21291925 0.77 TSHR (0.47) CYP2C9CYP2C19SMPD1ANPEPLAP3
SCHEMBL1297835 0.77 SRC (0.50) SRCCYP2C9CYP2C19ANPEPLAP3
SCHEMBL11300899 0.75 TSHR (0.41) MTNR1AMTNR1BTSHRALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11248011-B2 Phosphorus-based releasing agent, optical polymerizable composition comprising same and preparation thereof SKC CO., LTD. (KR) 2022-02-15 US claimed
US-20190263846-A1 PHOSPHORUS-BASED RELEASING AGENT, OPTICAL POLYMERIZABLE COMPOSITION COMPRISING SAME AND PREPARATION THEREOF SK PUCORE CO., LTD. (KR) 2019-08-29 US claimed
EP-3530684-A1 PHOSPHORUS-BASED RELEASING AGENT, OPTICAL POLYMERIZABLE COMPOSITION COMPRISING SAME AND PREPARATION THEREOF SKC Co., Ltd. (KR) 2019-08-28 EP claimed
CN-110183603-B Phosphorus-containing release agent, optical polymerizable composition containing same, and method for producing same SKC株式会社 2023-04-07 CN disclosed
US-11248011-B2 Phosphorus-based releasing agent, optical polymerizable composition comprising same and preparation thereof SKC CO., LTD. (KR) 2022-02-15 US disclosed
CN-110183603-A Phosphorous release agent, including its optics polymerizable composition, polymerizable composition and preparation method thereof SKC株式会社 2019-08-30 CN disclosed
US-20190263846-A1 PHOSPHORUS-BASED RELEASING AGENT, OPTICAL POLYMERIZABLE COMPOSITION COMPRISING SAME AND PREPARATION THEREOF SK PUCORE CO., LTD. (KR) 2019-08-29 US disclosed
EP-3530684-A1 PHOSPHORUS-BASED RELEASING AGENT, OPTICAL POLYMERIZABLE COMPOSITION COMPRISING SAME AND PREPARATION THEREOF SKC Co., Ltd. (KR) 2019-08-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190263846-A1 PHOSPHORUS-BASED RELEASING AGENT, OPTICAL POLYMERIZABLE COMPOSITION COMPRISING SAME AND PREPARATION THEREOF PMM2, PGM2, IPMK SRC 3409/4885CYP2C9 4463/4885CYP2C19 3998/4885
US-11248011-B2 Phosphorus-based releasing agent, optical polymerizable composition comprising same and preparation thereof PMM2, PGM2, IPMK SRC 3409/4885CYP2C9 4463/4885CYP2C19 3998/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.